Insights

Emerging Implantable CGM GlySens is a small, late-stage player focused on long-term, wireless implantable continuous glucose monitoring, presenting a potential strategic fit for partners or distributors seeking high-value, differentiated diabetes monitoring solutions with periodic, high-touch sales cycles.

Funding Momentum With a total funding of thirty-four million dollars and a recent fifteen million incremental financing, there may be near-term budget availability or investor-backed initiatives to accelerate product development, clinical validation, or regulatory activities that could open collaboration or co-development opportunities.

Limited U.S. Scale Small team size (2-10 employees) implies lean operations but also potential capacity constraints; a partnership with larger manufacturing, QA, or regulatory teams could help scale production, accelerate go-to-market planning, or broaden distribution channels.

Strategic Fit Opportunities Product focus on implantable CGM aligns with major players in diabetes care and diagnostics seeking next-gen monitoring technologies; potential opportunities include licensing, distribution, or joint development with larger medtech firms or contract manufacturing partners.

Clinical Validation Pathway As an investigational device with regulatory constraints, GlySens may benefit from collaborations that support clinical studies, data generation, and regulatory strategy, enabling faster trajectories toward broader adoption and payer conversations.

Similar companies to GlySens Incorporated

GlySens Incorporated Tech Stack

GlySens Incorporated uses 8 technology products and services including Amazon Web Services, git, Twemoji, and more. Explore GlySens Incorporated's tech stack below.

  • Cloud Hosting
  • git
    Development
  • Twemoji
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • iOS
    Programming Languages
  • Swift
    Programming Languages
  • Bootstrap
    UI Frameworks
  • prettyPhoto
    Web Tools And Plugins

GlySens Incorporated's Email Address Formats

GlySens Incorporated uses at least 3 email formats:
GlySens Incorporated Email FormatsExamplePercentage
FLast@glysens.comJDoe@glysens.com
70%
First.Last@glysens.comJohn.Doe@glysens.com
25%
FirstL@glysens.comJohnD@glysens.com
5%

Frequently Asked Questions

What is GlySens Incorporated's phone number?

Minus sign iconPlus sign icon
You can contact GlySens Incorporated's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is GlySens Incorporated's official website and social media links?

Minus sign iconPlus sign icon
GlySens Incorporated's official website is glysens.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does GlySens Incorporated generate?

Minus sign iconPlus sign icon
As of October 2026, GlySens Incorporated's annual revenue is estimated to be $1M - $10M.

What is GlySens Incorporated's NAICS code?

Minus sign iconPlus sign icon
GlySens Incorporated's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does GlySens Incorporated have currently?

Minus sign iconPlus sign icon
As of October 2026, GlySens Incorporated has approximately 5 employees across 1 continents, including North America. Key team members include Board Member: A. F. Explore GlySens Incorporated's employee directory with LeadIQ.

What industry does GlySens Incorporated belong to?

Minus sign iconPlus sign icon
GlySens Incorporated operates in the Medical Equipment Manufacturing industry.

What technology does GlySens Incorporated use?

Minus sign iconPlus sign icon
GlySens Incorporated's tech stack includes Amazon Web Services, git, Twemoji, yepnope.js, iOS, Swift, Bootstrap and prettyPhoto.

What is GlySens Incorporated's email format?

Minus sign iconPlus sign icon
GlySens Incorporated's email format typically follows the pattern of FLast@glysens.com. Find more GlySens Incorporated email formats with LeadIQ.

How much funding has GlySens Incorporated raised to date?

Minus sign iconPlus sign icon
As of October 2026, GlySens Incorporated has raised $34M in funding. The last funding round occurred on Jan 04, 2016 for $20M.

When was GlySens Incorporated founded?

Minus sign iconPlus sign icon
GlySens Incorporated was founded in 1998.
GlySens Incorporated logo

GlySens Incorporated

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

GlySens Incorporated is a small medical device company focused on diabetes management. It has developed a long-term, wireless implantable continuous glucose monitoring system, with the Eclipse ICGM System as its core technology. The device is designed to provide users with at-a-glance glucose data to support care decisions and simplify daily management. The system is labeled as investigational and limited by federal law to investigational use.

Based in San Diego, California, GlySens has operated since 1998 in the medical equipment manufacturing sector. Its target market comprises individuals with diabetes who require dependable, long-term glucose information to guide treatment decisions and daily management.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1998
Employees
2-10

Section iconFunding & Financials

  • $34M

    GlySens Incorporated has raised a total of $34M of funding over 4 rounds. Their latest funding round was raised on Jan 04, 2016 in the amount of $20M as a Series D.

  • $1M - $10M

    GlySens Incorporated's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.